In addition to TP53-mutations, overexpression of p16-protein [defined as “p16 (+)” in this study] in tumors, which is encoded by CDKN2A, increases survival time in cases of oropharyngeal cancer [12,13]. Here, TP53 is linked to oropharynx cancer.